1 déc
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

17 nov
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

10 nov
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

3 nov
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

20 oct
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

17 oct
9:00 | Atlanta, Georgia

2026 AABB Annual Meeting

The Association for the Advancement of Blood & Biotherapies (AABB) 2026 Annual Meeting will be October 17-19, 2026 in Atlanta, GA. The AABB Annual Meeting brings blood and biotherapies professionals together to share cutting-edge research, unique perspectives, networking with colleagues and practice
Transfusion

13 oct
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

6 oct
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

22 Sep
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion

15 Sep
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des
Transfusion
Subscribe to